Bgm (BGM) Invested Capital (2019 - 2025)

Bgm (BGM) posted quarterly Invested Capital of $1.6 million for Q3 2025, up 1.02% quarter-over-quarter from $1.6 million in Q1 2025.

Bgm (BGM) Invested Capital (2019 - 2025) Analysis & Trends

Bgm (BGM) has reported Invested Capital for 5 consecutive years, with $1.6 million the latest figure, recorded in Q3 2025.

In Q3 2025, Invested Capital changed N/A year-over-year to $1.6 million; the TTM figure through Sep 2025 stood at $3.2 million (up 571.34% YoY), while the FY2025 annual figure was $1.6 million, changed N/A from the prior year.
Invested Capital improved to $1.6 million in Q3 2025 per BGM's latest filing, from $1.6 million in the prior quarter.
Across five years, Invested Capital topped out at $3153.0 billion in Q1 2022 and bottomed at $140578.0 in Q3 2022.
Historically, Invested Capital has averaged $630.6 billion across 3 years, with a median of $1.6 million in 2025.
On a YoY basis, Invested Capital climbed as much as 241.24% in 2023 and fell as far as 241.24% in 2023.
Bgm's Invested Capital stood at $140578.0 in 2022, then jumped by 241.24% to $479715.0 in 2023, then soared by 237.38% to $1.6 million in 2025.
Business Quant data shows BGM's Invested Capital at $1.6 million in Q3 2025, $1.6 million in Q1 2025, and $479715.0 in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Haleon	43.91 Bn	42.95 Bn	-	9.90 Bn
2	Teva Pharmaceutical Industries	43.15 Bn	39.49 Bn	2.15 Bn	4.50 Bn
3	Zoetis	31.52 Bn	29.84 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.58 Bn	22.78 Bn	5.10 Bn	3.74 Bn
5	United Therapeutics	22.16 Bn	19.50 Bn	683.80 Mn	-
6	Viatris	18.76 Bn	17.87 Bn	1.46 Bn	1.74 Bn
7	Neurocrine Biosciences	15.48 Bn	15.09 Bn	935.80 Mn	-
8	Elanco Animal Health	11.69 Bn	11.16 Bn	798.00 Mn	73.00 Mn
9	Dr Reddys Laboratories	10.13 Bn	9.96 Bn	-	630.00 Mn
10	Bgm	29.89 Mn	20.07 Mn	-	1.62 Mn

Download Data